CheapInsurance.com reports that a new $2,000 out-of-pocket cap under Medicare Part D will save millions, but challenges ...
Telemedicine significantly improved quality of life and inhaler technique in advanced COPD patients compared to traditional ...
GlaxoSmithKline Plc said on Wednesday the U.S health regulator approved its lung disease drug Trelegy Ellipta for expanded use, making it the first inhaler delivering three drugs at once to be ...
Inhalers help millions of people breathe easier each day and can often be a lifeline for many who suffer from a host of ...
There are different kinds of asthma, like nocturnal asthma, allergic asthma, and occupational asthma. Here's what causes and ...
Inhaled versions of COVID-19 vaccine candidates developed by Oxford University and Imperial College will be trialled to see if they deliver a localised immune response in the respiratory tract, ...
Obstructive sleep apnoea (OSA) affects up to 1 billion people worldwide and is defined by repeated upper airway collapse ...
Jascayd targets the enzyme PDE4B, which plays a role in the inflammatory process. The new therapy is able to affect both fibrosis and the immune system. It will be available in the next few weeks.
The FDA granted approval to nerandomilast, now Jascayd, for treating adults with idiopathic pulmonary fibrosis, marking the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback